REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
20 hedge funds and large institutions have $34.4M invested in REVIVA PHARMA HLDGS INC in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
81% more capital invested
Capital invested by funds: $19M → $34.4M (+$15.4M)
54% more funds holding
Funds holding: 13 → 20 (+7)
17.89% more ownership
Funds ownership: 23.39% → 41.28% (+18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$3.55M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.23M |
| 3 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$1.95M |
| 4 |
Walleye Trading
New York
|
+$1.88M |
| 5 |
MSU
Mizuho Securities USA
New York
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$491K |
RVPH Hedge Fund Activity: Q1 2019 in Review
20 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q1 2019, worth a combined $34.4M — up 81% from $19M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new RVPH positions and 1 closed out — a net gain of 8 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Karpus Investment Management, opening a new position worth an estimated $3.55M. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $491K sold.
- 20 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q1 2019, up from 13 in Q4 2018.
- Funds reported $34.4M of REVIVA PHARMA HLDGS INC stock for Q1 2019, up 81% quarter-over-quarter.
- 9 funds opened new REVIVA PHARMA HLDGS INC positions in Q1 2019 and 1 closed out, a net change of +8 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q1 2019 was Karpus Investment Management, an estimated $3.55M added.
- The largest REVIVA PHARMA HLDGS INC seller in Q1 2019 was Glazer Capital LLC, an estimated $491K sold.
Based on aggregated 13F filings for Q1 2019.